With a global team of industry experts, DelveInsight is committed to fostering innovation and driving success in the healthcare industry through comprehensive, data-driven insights.
Actualizaciones Recientes
-
Burn Injuries Market: Analysis of Epidemiology, Pipeline Products, and Key Companies Involved, DelveInsightBurn Pain Market Insights by DelveInsight New treatments for burn pain are expected to significantly boost the burn pain market over the next few years. DelveInsight has launched a new report titled: "Burn Pain - Market Insights, Epidemiology, and Market Forecast - 2034."It provides a detailed analysis of burn pain, historical and projected epidemiology, and market trends in the US, EU5...0 Commentarios 0 Acciones 5 Views 0 Vista previaPlease log in to like, share and comment!
-
Chronic Idiopathic Urticaria Clinical and Nonclinical Studies, Key Companies, Treatment Evaluation, Emerging Therapies, Treatment Algorithms, Pipeline Analysis | United BioPharma, Teva Pharmaceuticals Development, Inc., Amgen, Novartis PharmaceuticalsChronic Idiopathic Urticaria Pipeline Insight, DelveInsightDelveInsight analyzes the chronic idiopathic urticaria (CIU) pipeline, profiling 15+ leading companies focused on developing 20+ treatments for CIU. Overview of chronic idiopathic urticaria: Chronic urticaria (CU) has characteristics. Recurrent wheals are Visible most daysAt least 6 weeksCUs are classified as follows: Chronic...0 Commentarios 0 Acciones 3 Views 0 Vista previa
-
Deep Partial Burns: Clinical and Non-Clinical Studies, Key Players, Treatment Evaluation, Emerging Therapies, Treatment Algorithms, and Pipeline Analysis | CUTISS AG, Skingenix, Polynovo, Mallinckrodt Pharmaceuticals, Kericis, MediWoundPipeline Insights Through Deep Partial Thickness Thermal Burning | DelveInsightAccording to DelveInsight's analysis, the deep partial burn pipeline consists of more than five leading companies, continually working on the development of more than five treatments for deep partial burn injuries. Overview of Deep Partial BurnsDeep partial-thickness burns affect both the epidermis and...0 Commentarios 0 Acciones 5 Views 0 Vista previa
-
Moderate to severe plaque psoriasis clinical and non-clinical studies, key players, treatment evaluation, emerging therapies, treatment algorithms, pipeline analysis | Bristol-Myers Squibb, Akeso Biopharma, Jiangsu Hengrui PharmaceuticalModerate-to-Severe Plaque Psoriasis Pipeline Insights, DelveInsight Moderate to severe plaque psoriasis companies include Nimbus Therapeutics, Sun Pharmaceutical Industries Limited, Suzhou Zelgen Biopharmaceuticals, GC Cell Corporation, Bioeq GmbH, Dong-A ST Co., Ltd., Can-fite Biopharma, Bio-thera solutions, AbbVie, Sinocelltech, Janssen Research and Development, Innovent Biologics,...0 Commentarios 0 Acciones 4 Views 0 Vista previa
-
Common Warts Clinical and Non-Clinical Studies, Key Companies, Treatment Evaluation, Emerging Therapies, Treatment Algorithms, and Pipeline Analysis | Verrica Pharmaceuticals, X4 Pharmaceuticals, Phio Pharmaceuticals, Kino Pharma, NIELSEN BioSciencesCommon Warts Pipeline Insights, DelveInsightAccording to DelveInsight's analysis, the common warts pipeline involves at least five leading companies that are continuously working on developing five or more treatments for common warts. Overview of Common Warts: WartsNoncancerous growthsDisplayed inSkin and mucous membranesDue to infection caused byHuman papillomavirus (HPV), including the...0 Commentarios 0 Acciones 5 Views 0 Vista previa
-
Hidradenitis Suppurativa clinical and non-clinical studies, key companies, treatment evaluation, emerging therapies, treatment algorithms, and pipeline analysis | InflaRx, Novartis, UCB, ChemoCentryx, Eli Lilly and Company, Janssen Biotech, AbbVie, PfizerHidradenitis Suppurativa Pipeline Insights, DelveInsight As reported by DelveInsight, the hidradenitis suppurativa (HS) pipeline consists of more than 24 prominent companies actively working on developing over 24 therapeutic options for the treatment of HS. Overview of hidradenitis suppurativa: Hidradenitis Suppurativa (HS), also known as Acne vulgaris, teeth a Chronic inflammatory skin...0 Commentarios 0 Acciones 4 Views 0 Vista previa
-
Atopic dermatitis clinical and non-clinical studies, key players, treatment evaluation, emerging therapies, treatment algorithms, pipeline analysis | Dermavant Sciences, Pfizer, AOBiome, Allakos Inc., E-nitiate Biopharmaceuticals (Hangzhou) Co., Ltd.The atopic dermatitis (AD) space includes several key players, including Teres Bio, Qurient Co., Sun Pharmaceutical, Merck Sharp & Dohme LLC, Hangzhou Yirui Pharmaceutical Technology Co., Ltd., GI Innovation, AnaptysBio, MC2 Therapeutics, Akaal Pharma, Kiniksa Pharmaceuticals, Selection, Intrinsic Medicine, Genome & Company, and TWi Biotechnology. According to DelveInsight, the...0 Commentarios 0 Acciones 5 Views 0 Vista previa
-
Uremic pruritus clinical and non-clinical studies, key companies, treatment evaluation, emerging therapies, treatment algorithms, and pipeline analysis | Sol-Gel Technologies Co., Ltd., Crystal Biotech Co., Ltd.Uremic Pruritus Pipeline Insights, DelveInsightAs revealed by DelveInsight's analysis, the uremic pruritus pipeline contains at least two major companies actively working on developing novel treatments for uremic pruritus. Overview of uremic pruritus:Uremic pruritus (UP), also known as chronic kidney disease-associated pruritus (CKD-aP), is a prevalent and often distressing symptom in patients...0 Commentarios 0 Acciones 4 Views 0 Vista previa
-
Uremic pruritus clinical and non-clinical studies, key companies, treatment evaluation, emerging therapies, treatment algorithms, and pipeline analysis | Sol-Gel Technologies Co., Ltd., Crystal Biotech Co., Ltd.Uremic Pruritus Pipeline Insights, DelveInsightAs revealed by DelveInsight's analysis, the uremic pruritus pipeline contains at least two major companies actively working on developing novel treatments for uremic pruritus. Overview of uremic pruritus:Uremic pruritus (UP), also known as chronic kidney disease-associated pruritus (CKD-aP), is a prevalent and often distressing symptom in patients...0 Commentarios 0 Acciones 6 Views 0 Vista previa
-
Strategic Pharmaceutical Partnerships: Maximizing Value Through CDMO CollaborationThe pharmaceutical industry's competitive landscape has fundamentally shifted toward collaborative partnerships that leverage specialized expertise and shared resources. This strategic evolution has created new paradigms for drug development and manufacturing, where success increasingly depends on selecting and managing the right external partnerships. Building Strategic Alliances...0 Commentarios 0 Acciones 4 Views 0 Vista previa
-
Breast Cancer Insights: Identifying Symptoms and Protecting Your HealthBreast cancer is a disease where cells in the breast grow uncontrollably, often forming a lump or mass. It’s one of the most common cancers among women worldwide. Recognizing early breast cancer symptoms—such as a new lump, skin changes, or nipple discharge—can be lifesaving. Knowing the signs of breast cancer and seeking prompt medical attention is crucial....0 Commentarios 0 Acciones 4 Views 0 Vista previa
-
Radiation Dermatitis Clinical and Non-Clinical Studies, Key Companies, Treatment Evaluation, Emerging Therapies, Treatment Algorithms, Pipeline Analysis | Matrix Biomed, Lutris Pharma, First String Research, Joben BiomedicalRadiation Dermatitis Pipeline Insights, DelveInsight According to DelveInsight's analysis, the radiation dermatitis pipeline consists of at least three major companies actively developing multiple treatments for radiation dermatitis. Overview of radiation dermatitis: Radiation dermatitis is a skin condition resulting from exposure to external ionizing radiation. Also known as radiation...0 Commentarios 0 Acciones 5 Views 0 Vista previa
-
Clinical and non-clinical studies of palmoplantar pustulosis, major companies, treatment evaluation, emerging therapies, treatment algorithms, pipeline analysisPalmoplantar pustulosis pipeline insights, DelveInsight According to DelveInsight, the palmoplantar pustulosis (PPP) pipeline consists of over eight leading companies actively developing over eight treatments for palmoplantar pustulosis. Overview of palmoplantar pustulosis: Palmoplantar pustulosis (PPP) is a rare, recurrent inflammatory disease. People affected by the condition develop small...0 Commentarios 0 Acciones 5 Views 0 Vista previa
-
Chronic Spontaneous Urticaria Clinical and Nonclinical Studies, Key Companies, Treatment Evaluation, Emerging Therapies, Treatment Algorithms, Pipeline Analysis | United BioPharma, Teva Pharmaceuticals Development, Inc., Amgen, Novartis PharmaceuticalsPipeline insights for chronic spontaneous urticaria, DelveInsight According to DelveInsight analysis, the chronic spontaneous urticaria (CSU) pipeline consists of more than 20 leading companies actively developing more than 20 treatments for CSU. Overview of Chronic Spontaneous Urticaria: Urticaria, commonly known as hives, wheals, or nettle rash, is characterized by itchy, red,...0 Commentarios 0 Acciones 4 Views 0 Vista previa
Quizás te interese…